Ardent Health Partners, LLC (ARDT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ardent Health Partners, LLC (ARDT) trades at $10.62 with AI Score 75/100 (Grade A). Ardent Health Partners, LLC operates a network of hospitals and clinics providing healthcare services in the United States. Market cap: $1.52B, Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: May 9, 2026ARDT stock analysis for 2026: Analysts have set a consensus price target of $13.07 for Ardent Health Partners, LLC, suggesting 23.0% upside from the current price of $10.62. The AI MoonshotScore is 75/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
ARDT: 3/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Ardent Health Partners, LLC (ARDT) Healthcare & Pipeline Overview
Ardent Health Partners, LLC, a subsidiary of EGI-AM Investments, L.L.C., owns and operates a network of hospitals and clinics in the U.S., delivering acute care, rehabilitation, and surgical services. With a $1.52B market cap and a P/E ratio of 9.7, the company maintains a 2.1% profit margin within the healthcare sector.
What Is the Investment Thesis for ARDT?
Ardent Health Partners, LLC presents a compelling investment case based on its established network of hospitals and clinics and its focus on diverse healthcare services. With a market capitalization of $1.52B and a P/E ratio of 9.7, Ardent demonstrates financial stability within the healthcare sector. A key value driver is the company's ability to maintain a solid gross margin of 49.7%, indicating efficient cost management. Growth catalysts include potential expansion into underserved markets and the increasing demand for rehabilitation and surgical services. However, investors may want to evaluate potential risks such as regulatory changes and competition from other healthcare providers like ImmunityBio, Inc. (IBRX).
Based on FMP financials and quantitative analysis
ARDT Key Highlights
Market capitalization of $1.52B, indicating a substantial presence in the healthcare market.
- P/E ratio of 9.7, suggesting a potentially undervalued stock compared to industry peers.
- Gross margin of 49.7%, reflecting efficient cost management and strong revenue generation.
- Profit margin of 2.1%, demonstrating profitability in a competitive healthcare environment.
- Beta of 0.45, indicating lower volatility compared to the overall market.
Who Are ARDT's Competitors?
ARDT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | $8.13 | +5.31% | $8.51B | — |
| HCSG Healthcare Services Group, Inc. | $22.93 | +4.51% | $1.57B | 94 |
| PNTG The Pennant Group, Inc. | $39.14 | -0.66% | $1.36B | 71 |
| AMN AMN Healthcare Services, Inc. | $34.79 | -1.50% | $1.35B | 91 |
| AMEH Apollo Medical Holdings, Inc. | $40.82 | -2.11% | $1.83B | 55 |
| RAFLF Raffles Medical Group Ltd | $0.67 | -10.67% | $1.23B | 54 |
| USPH U.S. Physical Therapy, Inc. | $79.21 | +1.28% | $1.21B | 60 |
| ASTH Astrana Health, Inc. | $39.40 | +0.61% | $1.95B | 78 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ARDT's Key Strengths?
Established network of hospitals and clinics.
- Comprehensive range of healthcare services.
- Strong geographic presence in key markets.
- Experienced management team.
What Are ARDT's Weaknesses?
Reliance on third-party payers (insurance companies and government programs).
- Exposure to regulatory changes and healthcare policy reforms.
- Potential for increased competition from other healthcare providers.
- Sensitivity to economic downturns and fluctuations in patient volumes.
What Could Drive ARDT Stock Higher?
Potential expansion into new geographic markets, increasing patient volume and revenue.
- Continued investment in advanced medical technologies, improving patient outcomes and attracting top medical talent.
- Strategic partnerships with physicians and healthcare providers, enhancing service offerings and geographic reach.
What Are the Key Risks for ARDT?
Changes in healthcare regulations and reimbursement rates, impacting revenue and profitability.
- Increased competition from other healthcare providers, potentially leading to price pressures and market share erosion.
- Rising costs of medical supplies and equipment, affecting profit margins.
- Cyberattacks and data breaches, compromising patient data and disrupting operations.
What Are the Growth Opportunities for ARDT?
- Expansion into Underserved Markets: Ardent can expand its presence by establishing new facilities or acquiring existing ones in underserved geographic areas. The market for healthcare services in rural and remote regions is substantial, with a potential market size of billions of dollars. This expansion can be achieved within the next 3-5 years, providing a first-mover advantage and establishing a strong foothold in these markets. Competitive advantages include Ardent's established operational expertise and its ability to deliver a comprehensive range of healthcare services.
- Increased Focus on Telehealth Services: Telehealth is a rapidly growing segment of the healthcare industry, offering convenient and cost-effective access to medical care. Ardent can invest in expanding its telehealth capabilities to reach a broader patient base and improve patient outcomes. By leveraging technology and partnerships, Ardent can enhance its competitive position and capture a significant share of this growing market. This initiative can be implemented within the next 1-2 years.
- Strategic Acquisitions and Partnerships: Ardent can pursue strategic acquisitions and partnerships to expand its service offerings and geographic reach. By acquiring smaller healthcare providers or partnering with specialized clinics, Ardent can diversify its revenue streams and enhance its competitive position. The market for healthcare acquisitions is active, with numerous opportunities available. These strategic moves can be executed within the next 2-3 years, providing immediate synergies and long-term growth potential.
- Investment in Advanced Medical Technologies: Ardent can invest in advanced medical technologies, such as robotic surgery and AI-powered diagnostics, to improve patient outcomes and attract top medical talent. The market for medical technologies is constantly evolving, with new innovations emerging regularly. By staying at the forefront of technological advancements, Ardent can enhance its reputation as a leading healthcare provider and attract a larger patient base. This ongoing investment can yield significant returns over the next 5-10 years.
- Enhancement of Rehabilitation Services: With an aging population and increasing incidence of chronic diseases, the demand for rehabilitation services is growing. Ardent can expand its rehabilitation facilities and programs to meet this growing demand. By offering comprehensive rehabilitation programs and personalized care, Ardent can establish a strong competitive advantage and capture a significant share of this market. This expansion can be phased in over the next 3-5 years.
What Are ARDT's Competitive Advantages?
- Established network of hospitals and clinics provides a strong geographic presence.
- Comprehensive range of healthcare services caters to diverse patient needs.
- Reputation for quality care and patient satisfaction.
- Strategic partnerships with physicians and healthcare providers.
- Operational expertise and efficient cost management.
What Does ARDT Do?
Founded in 2001 and based in Brentwood, Tennessee, Ardent Health Partners, LLC owns and operates a network of hospitals and clinics throughout the United States. As a subsidiary of EGI-AM Investments, L.L.C., Ardent focuses on providing a comprehensive range of healthcare services, including acute care, rehabilitation, and surgical procedures. The company's network is designed to meet diverse patient needs, offering both inpatient and outpatient services. Ardent's facilities include acute care hospitals equipped to handle a wide array of medical conditions, rehabilitation hospitals focused on helping patients recover from injuries and illnesses, and surgical hospitals specializing in elective and emergency surgical procedures. Ardent's strategic geographic footprint allows it to serve various communities, contributing to its established presence in the healthcare market. The company employs approximately 19,200 individuals, reflecting its significant operational scale and commitment to delivering quality healthcare services. Ardent's focus on operational efficiency and patient care positions it as a key player in the healthcare landscape.
What Products and Services Does ARDT Offer?
- Owns and operates a network of acute care hospitals.
- Provides rehabilitation services to patients recovering from injuries and illnesses.
- Offers surgical services, including elective and emergency procedures.
- Manages a network of clinics providing outpatient care.
- Delivers a range of healthcare services to communities across the United States.
- Focuses on improving patient outcomes through quality care and advanced medical technologies.
- Operates as a subsidiary of EGI-AM Investments, L.L.C.
How Does ARDT Make Money?
- Generates revenue through patient services, including hospital stays, surgeries, and clinic visits.
- Receives payments from insurance companies, government programs (e.g., Medicare and Medicaid), and self-paying patients.
- Manages costs through efficient operations and strategic sourcing of medical supplies and equipment.
- Reinvests profits into facility improvements, technology upgrades, and expansion initiatives.
What Industry Does ARDT Operate In?
Ardent Health Partners, LLC operates within the dynamic and competitive healthcare industry. The industry is characterized by increasing demand for healthcare services, driven by an aging population and advancements in medical technology. Key trends include the consolidation of healthcare providers and the growing emphasis on value-based care. Ardent competes with other hospital networks and healthcare facilities, including ImmunityBio, Inc. (IBRX), in a fragmented market. The company's focus on acute care, rehabilitation, and surgical services positions it to capitalize on these trends.
Who Are ARDT's Key Customers?
- Individuals seeking acute care for illnesses and injuries.
- Patients requiring rehabilitation services after surgery or illness.
- Individuals in need of surgical procedures.
- Patients seeking outpatient care and preventive services.
- Communities served by Ardent's network of hospitals and clinics.
Insider Activity
Over the past six months, Ardent Health Partners, LLC insiders filed 30 SEC Form 4 transactions — 9 sales and 21 purchases. On net that is roughly 622K shares acquired (about $103K) — insiders putting money in tends to read as conviction.
Quarterly Financial Performance: Ardent Health Partners, LLC
Revenue for Ardent Health Partners, LLC came in at $1.62B during Q2 2026, a 1.3% improvement versus the preceding quarter. The company recorded net income of $16.9M, with diluted EPS of $0.12. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, ARDT averaged $0.14 in diluted EPS.
ARDT Valuation & Market Position
With a $1.52B market cap, Ardent Health Partners, LLC sits in the small-cap segment of the market. Relative to its peer group, ARDT's quantitative score of 75/100 is roughly in line with the peer average of 78/100.
Key Financial Metrics
Return on equity for Ardent Health Partners, LLC stands at 9.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.6%, showing how much profit it generates from its asset base. ARDT trades at a trailing price-to-earnings ratio of 9.71, below the Healthcare sector average of ~23x. Its free cash flow yield is 16.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.12 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 10.3%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Ardent Health Partners, LLC's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.02 places it in the grey zone, a middle ground that warrants monitoring.
Forward Outlook
Wall Street analysts project Ardent Health Partners, LLC revenue of about $6.45B for fiscal 2026, with EPS near $1.02. The estimate reflects 7 contributing analysts.
Company Profile
Ardent Health Partners, LLC operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Brentwood, US. The company is led by CEO Martin J. Bonick. ARDT has traded publicly since 2024.
ARDT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established network of hospitals and clinics.
- Comprehensive range of healthcare services.
- Strong geographic presence in key markets.
- Experienced management team.
Bear Case
- Reliance on third-party payers (insurance companies and government programs).
- Exposure to regulatory changes and healthcare policy reforms.
- Potential for increased competition from other healthcare providers.
- Sensitivity to economic downturns and fluctuations in patient volumes.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $1.62B | $17M | $0.12 |
| Q1 2026 | $1.60B | $40M | $0.28 |
| Q4 2025 | $1.61B | $45M | $0.32 |
| Q3 2025 | $1.58B | -$23M | -$0.17 |
Based on FMP financials and quantitative analysis
ARDT Latest News
-
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date
businesswire.com · Jul 17, 2026
-
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
Yahoo! Finance: ARDT News · Jul 15, 2026
-
Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12
benzinga · Jul 14, 2026
-
RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $12
benzinga · Jul 9, 2026
ARDT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ARDT.
Price Targets
Consensus target: $13.07
ARDT MoonshotScore
What does this score mean?
The MoonshotScore rates ARDT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Latest News
Ardent Health Announces Second Quarter 2026 Results Conference Call and Webcast Date
Elevance Health (ELV) Surpasses Q2 Earnings and Revenue Estimates
Truist Securities Maintains Buy on Ardent Health, Lowers Price Target to $12
RBC Capital Maintains Outperform on Ardent Health, Lowers Price Target to $12
Latest Ardent Health Partners, LLC Analysis
IWM Jumps 1.32% Amid Western Digital's $4B Buyback Plan
2 min readArdent Health (ARDT) Faces Scrutiny Amid Accounting Allegations; Stock Up 1.27%
2 min readSecurities Lawsuits Hit ARDT (+4.18%) and RR (-6.57%) Amidst Market Uncertainty
2 min readLawsuit News Weighs on Stocks: CRWV Up 7.60% Amidst Broader Market Gains
2 min readMarket Momentum Continues: SPY Up 1.92% Amidst Lawsuit Alerts for ARDT, CPNG, and FFIV
2 min readLeadership: Martin J. Bonick
Unknown
Martin J. Bonick manages approximately 19,200 employees at Ardent Health Partners, LLC. Additional background information on his career history, education, and previous roles is not available within the provided data.
Track Record: Information regarding Martin J. Bonick's specific achievements, strategic decisions, and company milestones under his leadership at Ardent Health Partners, LLC is not available in the provided data.
What Investors Ask About Ardent Health Partners, LLC (ARDT) — Healthcare
What does the AI Score mean for ARDT?
ARDT holds an AI Score of 75/100 (Grade: A). This is an educational research signal, not a buy or sell recommendation. Ardent Health Partners, LLC operates a network of hospitals and clinics providing healthcare services in the United States. The company focuses on acute care, rehabilitation, and surgical hospital …
What does Ardent Health Partners, LLC do?
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics in the United States, providing a range of healthcare services. These services include acute care, rehabilitation, and surgical procedures. The company's business model revolves around delivering comprehensive medical care to patients through its network of facilities, generating revenue from patient services, insurance reimbursements, and government programs.
What do analysts say about ARDT stock?
Analyst opinions on Ardent Health Partners, LLC (ARDT) are not available based on the provided data. Key valuation metrics include a market capitalization of $1.52B and a P/E ratio of 9.7. Growth considerations involve the company's ability to expand into new markets, invest in advanced technologies, and manage costs effectively.
What are the main risks for ARDT?
Ardent Health Partners, LLC faces several risks inherent in the healthcare industry. These include potential changes in healthcare regulations and reimbursement rates, which could impact revenue and profitability. Increased competition from other healthcare providers may lead to price pressures and market share erosion. Rising costs of medical supplies and equipment can affect profit margins.
What are the key factors to evaluate for ARDT?
Ardent Health Partners, LLC (ARDT) holds an AI score of 75/100 (high). P/E: 9.7x vs the S&P 500's ~20-25x. Analysts target $13.07 (+23%). Not financial advice.
How frequently does ARDT data refresh on this page?
ARDT's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ARDT's recent stock price performance?
Ardent Health Partners, LLC (ARDT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of hospitals and clinics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ARDT overvalued or undervalued right now?
Ardent Health Partners, LLC (ARDT) trades at 9.7x earnings. Analysts target $13.07 (+23%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ARDT before investing?
Before investing in Ardent Health Partners, LLC (ARDT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may not be exhaustive.
- Analyst opinions and future projections are subject to change.